Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. Eguia Bernal"'
Autor:
K. I. González Márquez, M. Eguia Bernal, Ernesto Torres-López, M. A. Garza Elizondo, Andres Mendiola-Jimenez, S. A. Loredo Alanis, D. D. Castañeda Martínez, M. M. Castañeda-Martínez, B. R. Vázquez Fuentes, P. Herrera-Sandate, G. E. Rodriguez-Sanchez, A. Cárdenas, Leendert A. Trouw, David Vega-Morales, D. Á. Galarza-Delgado, T. S. Gracia-Arechiga, Mario C. Salinas-Carmona, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 80:1085-1086
Background:Clinically relevant anti-carbamylated (anti-CarP) antibodies are detected in up to 45% of rheumatoid arthritis (RA) patients and are associated with severe radiological progression, higher disease activity, and significantly more disabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a90b372a15adfdce541aa81f13b5104
https://doi.org/10.1136/annrheumdis-2021-eular.1289
https://doi.org/10.1136/annrheumdis-2021-eular.1289
Autor:
M. Eguia Bernal, Griselda Serna-Peña, D. Á. Galarza-Delgado, David Vega-Morales, R. Pineda-Sic, M. M. Castañeda-Martínez, L. Santoyo-Fexas, D. E. Flores Alvarado, L. Pérez Barbosa, Janett Riega-Torres, Miguel Ángel Villarreal-Alarcón, I. D. J. Hernandez-Galarza
Publikováno v:
Annals of the Rheumatic Diseases. 79:899.2-899
Background:Rheumatoid Factor (RF) is used for the classification of Rheumatoid arthritis (RA) in patients whose main complaint is hand arthritis but is well known that other conditions have positive RF. Differences in analytical performance between a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::802123a0c687ad48878c8c9fa7a87dbb
https://doi.org/10.1136/annrheumdis-2020-eular.4039
https://doi.org/10.1136/annrheumdis-2020-eular.4039
Autor:
I. D. J. Hernandez-Galarza, D. Á. Galarza-Delgado, L. Santoyo-Fexas, C. M. Skinner Taylor, C. V. Solis, B. R. Vázquez Fuentes, R. A. Uriarte Botello, M. Eguia Bernal
Publikováno v:
Annals of the Rheumatic Diseases. 79:1935.1-1936
Background:Pharmacovigilance is the science and activities related to detection, evaluation, understanding and prevention of adverse effects of medications or any other health problem related to them. (1)Within the scope of the pharmacovigilance stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57dcd10686b1a7b5f6286225d816abea
https://doi.org/10.1136/annrheumdis-2020-eular.2218
https://doi.org/10.1136/annrheumdis-2020-eular.2218
Autor:
M. Eguia Bernal, R. A. Uriarte Botello, D. Á. Galarza-Delgado, B. R. Vázquez Fuentes, L. Santoyo-Fexas, C. M. Skinner Taylor, I. D. J. Hernandez-Galarza, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 79:1936-1936
Background:Medication error can be defined as a failure in the treatment process that leads to or has the potential to lead to harm to the patient, this fault can happen in two different phases: prescribing and prescription.Prescribing is the process
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b81a515c57517160aeb0b6a10b1d3fd1
https://doi.org/10.1136/annrheumdis-2020-eular.2940
https://doi.org/10.1136/annrheumdis-2020-eular.2940
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peña-Lizola SP; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Sordia-Hernandez LH; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Garcia-Luna SM; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Valdes-Martinez O; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Skinner-Taylor CM; Rheumatology and Immunology Service, Dr. Jose Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Garza-Elizondo MA; Rheumatology and Immunology Service, Dr. Jose Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Vidal-Gutierrez O; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Villarreal-Perez JZ; Department of Endocrinology, Dr. Jose Eleuterio González University Hospital, Autonomous University of Nuevo Leon. Monterrey, Mexico., Eguia-Bernal M; Rheumatology and Immunology Service, Dr. Jose Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico., Morales-Martinez FA; Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Dr. José Eleuterio Gonzalez University Hospital, Autonomous University of Nuevo Leon, Monterrey, Mexico.
Publikováno v:
Journal of family & reproductive health [J Family Reprod Health] 2021 Dec; Vol. 15 (4), pp. 236-241.